Literature DB >> 28968650

Response to comments on 'Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study'.

Efrat L Amitay1, Hermann Brenner1,2,3,4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 28968650     DOI： 10.1093/carcin/bgx093

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN： 0143-3334            Impact factor:   4.944


× No keyword cloud information.
  3 in total

1.  A Systematic Overview of Type II and III Toxin-Antitoxin Systems with a Focus on Druggability.

Authors:  Sung-Min Kang; Do-Hee Kim; Chenglong Jin; Bong-Jin Lee
Journal:  Toxins (Basel)       Date:  2018-12-04       Impact factor: 4.546

Review 2.  Fusobacterium nucleatum-positive colorectal cancer.

Authors:  Zhenhua Yang; Guang Ji
Journal:  Oncol Lett       Date:  2019-06-04       Impact factor: 2.967

3.  The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer.

Authors:  Kaixi Liu; Xinran Yang; Mi Zeng; Yumeng Yuan; Jianhong Sun; Ping He; Jiayu Sun; Qingdong Xie; Xiaolan Chang; Suwei Zhang; Xiang Chen; Leshan Cai; Yanxuan Xie; Xiaoyang Jiao
Journal:  Dis Markers       Date:  2021-11-22       Impact factor: 3.434
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.